{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:28:31Z","timestamp":1794324511336,"version":"4.9.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/mbc.0b013e3283424809","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T03:07:42Z","timestamp":1298430462000},"page":"176-184","source":"Crossref","is-referenced-by-count":17,"title":["D-dimer assay in Egyptian patients with Gaucher disease: correlation with bone and lung involvement"],"prefix":"10.1097","volume":"22","author":[{"given":"Eman M","family":"Sherif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza AG","family":"Tantawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira AM","family":"Adly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam A","family":"Kader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman AR","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl. 1","key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1007\/s00431-003-1348-y","article-title":"Lysosomal storage disorders: emerging therapeutic options require early diagnosis","volume":"162","author":"Meikle","year":"2003","journal-title":"Eur J Pediatr"},{"issue":"Suppl. 2","key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jpeds.2009.07.004","article-title":"Recommendations on the diagnosis, treatment, and monitoring of Gaucher disease","volume":"155","author":"Martins","year":"2009","journal-title":"J Pediatr"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejim.2006.07.005","article-title":"Epidemiology and natural history of Gaucher's disease","volume":"17","author":"Mehta","year":"2006","journal-title":"Eur J Intern Med"},{"key":"R4-4-20210203","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/138620708786734244","article-title":"Optimization and validation of two miniaturized glucocerebrosidase enzyme assays for high throughput screening","volume":"11","author":"Urban","year":"2008","journal-title":"Comb Chem High Throughput Screen"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jpeds.2004.01.050","article-title":"Gaucher disease: lessons from a decade of therapy","volume":"144","author":"Grabowski","year":"2004","journal-title":"J Pediatr"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.braindev.2005.04.005","article-title":"Type 2 Gaucher disease: 15 new cases and review of the literature","volume":"28","author":"Mignot","year":"2006","journal-title":"Brain Dev"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","article-title":"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype","volume":"76","author":"Orvisky","year":"2002","journal-title":"Mol Genet Metab"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ajh.10361","article-title":"D-Dimer assay in Gaucher disease: correlation with severity of bone and lung involvement","volume":"73","author":"Shitrit","year":"2003","journal-title":"Am J Hematol"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-2141.2007.06701.x","article-title":"Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease","volume":"138","author":"Hughes","year":"2007","journal-title":"Br J Haematol"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u2018simple\u2019 disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol Genet Metab"},{"issue":"Suppl. 1","key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0248-8663(06)80002-0","article-title":"Phenotype variations in Gaucher disease","volume":"27","author":"Mistry","year":"2006","journal-title":"Rev Med Interne"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br J Haematol"},{"issue":"Suppl. 1","key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1259\/bjr.75.suppl_1.750025","article-title":"Response of Gaucher bone disease to enzyme replacement therapy","volume":"75","author":"Poll","year":"2002","journal-title":"Br J Radiol"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7863\/jum.1997.16.3.209","article-title":"Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: comparison to computed tomographic measurements","volume":"16","author":"Elstein","year":"1997","journal-title":"J Ultrasound Med"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1185\/030079906X104623","article-title":"Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients","volume":"22","author":"Vom Dahl","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00256-007-0425-0","article-title":"Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease","volume":"37","author":"Maas","year":"2008","journal-title":"Skeletal Radiol"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1067\/mpd.2001.119445","article-title":"Gaucher disease with pulmonary involvement in a 6 years old girl: report of resolution of radiographic abnormalities","volume":"139","author":"Lee","year":"2001","journal-title":"J Pediatr"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.crad.2003.09.010","article-title":"Gaucher disease in children: radiology of noncentral nervous system manifestations","volume":"59","author":"McHugh","year":"2004","journal-title":"Clin Radiol"},{"key":"R21-4-20210203","first-page":"115","article-title":"Enzyme therapy for Gaucher disease: the first 5 years","volume":"9","author":"Grabowski","year":"2003","journal-title":"Blood Rev"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1096-7192(02)00122-1","article-title":"Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy","volume":"77","author":"Mistry","year":"2002","journal-title":"Mol Genet Metab"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1586\/epr.09.54","article-title":"Gaucher disease: a model disorder for biomarker discovery","volume":"6","author":"Boot","year":"2009","journal-title":"Expert Rev Proteomics"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa023153","article-title":"Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis","volume":"349","author":"Wells","year":"2003","journal-title":"N Engl J Med"},{"key":"R25-4-20210203","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/clinchem\/46.6.871","article-title":"Latex-enhanced immunoturbidimetry allows D-dimer determination in plasma and serum samples","volume":"46","author":"Korte","year":"2000","journal-title":"Clin Chem"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood-2005-12-5072","article-title":"Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis","volume":"108","author":"de Fost","year":"2006","journal-title":"Blood"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11318540-000000000-00000","article-title":"Recombinant glucocerebrosidase (imiglucerase) as a therapy for Gaucher disease","volume":"24","author":"Pastores","year":"2010","journal-title":"BioDrugs"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1517\/14656560903270520","article-title":"Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose-response relationships","volume":"10","author":"Hollak","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/clinchem\/48.9.1611","article-title":"No influence of heparin plasma and other (pre)analytic variables on D-dimer determinations","volume":"48","author":"Schutgens","year":"2002","journal-title":"Clin Chem"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1378\/chest.123.5.1375","article-title":"D-Dimer in acute aortic dissection","volume":"123","author":"Weber","year":"2003","journal-title":"Chest"},{"key":"R32-4-20210203","first-page":"462","article-title":"Does a negative D-dimer test rule out aortic dissection?","volume":"137","author":"Wieganda","year":"2007","journal-title":"Swiss Med Wkly"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"issue":"Suppl. 2","key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/S0248-8663(07)78880-X","article-title":"Current development and usefulness of biomarkers for Gaucher disease follow up","volume":"28","author":"Maire","year":"2007","journal-title":"Rev Med Intern"},{"key":"R35-4-20210203","first-page":"1","article-title":"An overview of Gaucher disease","volume":"1","author":"Barranger","year":"1993","journal-title":"Gaucher Clin Perspect"},{"key":"R36-4-20210203","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s004390000380","article-title":"Gene rearrangement on 1q21 introducing a duplication of the glucocerebrosidase pseudogene and a metaxin fusion gene","volume":"107","author":"Tayebi","year":"2000","journal-title":"Hum Genet"},{"key":"R37-4-20210203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/08035320600619039","article-title":"Gaucher disease: multiple lessons from a single gene disorder","volume":"95","author":"Beutler","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"R38-4-20210203","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajh.20011","article-title":"Rheological determinants in patients with Gaucher disease and internal inflammation","volume":"75","author":"Zimran","year":"2004","journal-title":"Am J Hematol"},{"key":"R39-4-20210203","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0248-8663(06)80002-0","article-title":"Phenotype variations in Gaucher disease","volume":"27","author":"Mistry","year":"2006","journal-title":"Rev Med Intern"},{"issue":"suppl.2","key":"R40-4-20210203","first-page":"37","article-title":"Immune dysfunction in patients with Gaucher disease: impact of disease severity and enzyme replacement therapy","volume":"95","author":"Khalifa","year":"2010","journal-title":"Haematologica"},{"key":"R41-4-20210203","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajh.21305","article-title":"Life expectancy in Gaucher disease type 1","volume":"83","author":"Weinreb","year":"2008","journal-title":"Am J Hematol"},{"key":"R42-4-20210203","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"R43-4-20210203","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1010514614570","article-title":"Management of neuronopathic Gaucher disease: a European consensus","volume":"24","author":"Vellodi","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"R44-4-20210203","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"The role of the iminosugar N butyldeoxynojirimycin (miglustat) in the management of type I (nonneuronopathic) Gaucher disease: a position statement","volume":"26","author":"Cox","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"R45-4-20210203","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/bcmd.2000.0310","article-title":"Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease","volume":"26","author":"Altarescu","year":"2000","journal-title":"Blood Cells Mol Dis"},{"key":"R46-4-20210203","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10545-006-0121-6","article-title":"Enzyme replacement therapy and bony changes in Egyptian pediatric Gaucher disease patients","volume":"29","author":"El-Beshlawy","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"R47-4-20210203","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/mgme.2001.3269","article-title":"Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: implications for the prediction of disease severity","volume":"75","author":"Whitfield","year":"2002","journal-title":"Mol Genet Metab"},{"key":"R48-4-20210203","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/08880010600623232","article-title":"Coagulation abnormalities in type 1 Gaucher disease in children","volume":"23","author":"Deghady","year":"2006","journal-title":"Pediatr Hematol Oncol"},{"key":"R49-4-20210203","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1538-7836.2003.00148.x","article-title":"The usefulness of five D-dimer assays in the exclusion of deep venous thrombosis","volume":"1","author":"Schutgens","year":"2003","journal-title":"J Thromb Haemost"},{"key":"R50-4-20210203","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF00441877","article-title":"Effect of splenectomy on destructive bone changes in children with chronic (type I) Gaucher disease","volume":"145","author":"Ashkenazi","year":"2003","journal-title":"Eur J Pediatr"},{"key":"R51-4-20210203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02021548","article-title":"Pulmonary Gaucher's disease: high-resolution computed tomographic features","volume":"25","author":"Tunaci","year":"1995","journal-title":"Pediatr Radiol"},{"key":"R52-4-20210203","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2009.07872.x","article-title":"Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis","volume":"147","author":"Mistry","year":"2009","journal-title":"Br J Haematol"},{"key":"R53-4-20210203","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1034\/j.1399-0004.2003.00060.x","article-title":"Pulmonary involvement in type I Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease","volume":"63","author":"Miller","year":"2003","journal-title":"Clin Genet"},{"key":"R54-4-20210203","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(98)10194-0","article-title":"Echocardiographic assessment of pulmonary hypertension in Gaucher disease","volume":"351","author":"Elstein","year":"1998","journal-title":"Lancet"},{"key":"R55-4-20210203","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/94.8.407","article-title":"Lung involvement and enzyme replacement therapy in Gaucher's disease","volume":"94","author":"Goitein","year":"2001","journal-title":"QJM"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0b013e3283424809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:53:28Z","timestamp":1786042408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201104000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e3283424809","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}